- $884.51m
- $1.25bn
- $1.33bn
- 73
- 80
- 56
- 79
2019 March 30th | 2020 March 28th | 2021 March 27th | 2022 March 26th | 2023 March 25th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,200 | 1,257 | 1,126 | 1,359 | 1,325 |
Cost of Revenue | |||||
Gross Profit | 465 | 477 | 395 | 482 | 456 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,073 | 1,155 | 1,053 | 1,258 | 1,246 |
Operating Profit | 127 | 102 | 72.2 | 101 | 79.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 100 | 74.3 | 44.2 | 77.3 | 57.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 79.8 | 58 | 34.3 | 61.6 | 39 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 79.8 | 58 | 34.3 | 61.6 | 39 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 79.3 | 57.6 | 33.9 | 61.1 | 38.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.37 | 1.95 | 1.41 | 2 | 1.21 |
Dividends per Share |